{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:40:29Z","timestamp":1787920829794,"version":"build-2784847793"},"reference-count":88,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Atypical parathyroid tumor (APT) represents a neoplasm characterized by histological features typical of parathyroid carcinoma (PC) but lacking local infiltration and\/or distant metastasis, leading to uncertainty regarding its malignant potential.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To characterize the molecular landscape and deregulated pathways in APT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Whole-exome sequencing (WES) was conducted on 16 APTs. DNA from tumors and matched peripheral blood underwent WES using Illumina HiSeq3000.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 192 nonsynonymous variants were identified. The median number of protein-altering mutations was 9. The most frequently mutated genes included BCOR, CLMN, EZH1, JAM2, KRTAP13-3, MUC16, MUC19, and OR1S1. Seventeen mutated genes belong to the Cancer Gene Census list. The most consistent hub genes identified through STRING network analysis were ATM, COL4A5, EZH2, MED12, MEN1, MTOR, PI3, PIK3CA, PIK3CB, and UBR5. Deregulated pathways included the PI3 K\/AKT\/mTOR pathway, Wnt signaling, and extracellular matrix organization. Variants in genes such as MEN1, CDC73, EZH2, PIK3CA, and MTOR, previously reported as established or putative\/candidate driver genes in benign adenoma (PA) and\/or PC, were also identified in APT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>APT does not appear to have a specific molecular signature but shares genomic alterations with both PA and PC. The incidence of CDC73 mutations is low, and it remains unclear whether these mutations are associated with a higher risk of recurrence. Our study confirms that PI3 K\/AKT\/mTOR and Wnt signaling represents the pivotal pathways in parathyroid tumorigenesis and also revealed mutations in key epigenetic modifier genes (BCOR, KDM2A, MBD4, and EZH2) involved in chromatin remodeling, DNA, and histone methylation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae441","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T12:42:17Z","timestamp":1719578537000},"page":"48-58","source":"Crossref","is-referenced-by-count":9,"title":["Whole-exome Sequencing of Atypical Parathyroid Tumors Detects Novel and Common Genes Linked to Parathyroid Tumorigenesis"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2405-1123","authenticated-orcid":false,"given":"Elena","family":"Pardi","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa , 56126 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anello Marcello","family":"Poma","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa , 56126 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liborio","family":"Torregrossa","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa , 56126 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pierotti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa , 56126 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Borsari","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa , 56126 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Della Valentina","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa , 56126 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa , 56126 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2558-9547","authenticated-orcid":false,"given":"Filomena","family":"Cetani","sequence":"additional","affiliation":[{"name":"Department of Surgery and Endocrine Metabolic and Transplant Medicine, Endocrine Unit, Pisa, University Hospital of Pisa , 56124 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"issue":"10116","key":"2024121723534037300_dgae441-B1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"2024121723534037300_dgae441-B2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/clinem\/dgad455","article-title":"Approach to the patient with parathyroid carcinoma","volume":"109","author":"Cetani","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024121723534037300_dgae441-B3","doi-asserted-by":"crossref","first-page":"R441","DOI":"10.1530\/ERC-19-0135","article-title":"Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors","volume":"26","author":"Cetani","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2024121723534037300_dgae441-B4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO classification of parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"issue":"10","key":"2024121723534037300_dgae441-B5","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/jamaoto.2023.2342","article-title":"Somatic and germline mutations in atypical parathyroid tumors","volume":"19","author":"Ullmann","year":"2023","journal-title":"JAMA Otolaryngol Neck Surg"},{"key":"2024121723534037300_dgae441-B6","doi-asserted-by":"crossref","first-page":"6666257","DOI":"10.1155\/2021\/6666257","article-title":"Genetic alteration profiles and clinicopathological associations in atypical parathyroid adenoma","volume":"2021","author":"Mao","year":"2021","journal-title":"Int J Genomics"},{"issue":"1","key":"2024121723534037300_dgae441-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ccr3.8440","article-title":"Late recurrence of a single gland primary hyperparathyroidism \u2014 atypical parathyroid adenoma or misdiagnosed parathyroid carcinoma","volume":"12","author":"Kotliarevskaia","year":"2024","journal-title":"Clin Case Rep"},{"issue":"4","key":"2024121723534037300_dgae441-B8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/BF00353773","article-title":"Clinical course of metastatic parathyroid cancer","volume":"18","author":"Sandelin","year":"1994","journal-title":"World J Surg"},{"issue":"11","key":"2024121723534037300_dgae441-B9","doi-asserted-by":"crossref","first-page":"E4565","DOI":"10.1210\/clinem\/dgab452","article-title":"Do patients with atypical parathyroid adenoma need close follow-up?","volume":"106","author":"Saponaro","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024121723534037300_dgae441-B10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2265.2006.02534.x","article-title":"Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome","volume":"65","author":"Mizusawa","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2024121723534037300_dgae441-B11","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/jc.2012-1743","article-title":"Identification of somatic mutations in parathyroid tumors using whole-exome sequencing","volume":"97","author":"Cromer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024121723534037300_dgae441-B12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12020-016-0892-y","article-title":"EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms","volume":"54","author":"Sanpaolo","year":"2016","journal-title":"Endocrine"},{"issue":"3","key":"2024121723534037300_dgae441-B13","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s12020-016-1142-z","article-title":"EZH2 copy number and mutational analyses in sporadic parathyroid adenomas","volume":"55","author":"Romano","year":"2016","journal-title":"Endocrine"},{"key":"2024121723534037300_dgae441-B14","first-page":"1","article-title":"Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2024121723534037300_dgae441-B15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-13-0046","article-title":"CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer","volume":"2","author":"Cetani","year":"2013","journal-title":"Endocr Connect"},{"issue":"1","key":"2024121723534037300_dgae441-B16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features","volume":"43","author":"Gill","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2024121723534037300_dgae441-B17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","article-title":"Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas","volume":"21","author":"Kruijff","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2024121723534037300_dgae441-B18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/modpathol.2010.236","article-title":"Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma","volume":"24","author":"Witteveen","year":"2011","journal-title":"Mod Pathol"},{"issue":"8","key":"2024121723534037300_dgae441-B19","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41379-019-0252-6","article-title":"Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center","volume":"32","author":"Juhlin","year":"2019","journal-title":"Mod Pathol"},{"key":"2024121723534037300_dgae441-B20","first-page":"145","volume-title":"WHO Classification of Tumors of Endocrine Organs","author":"DeLellis","year":"2017","edition":"4th ed"},{"issue":"19","key":"2024121723534037300_dgae441-B21","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1093\/bioinformatics\/bts480","article-title":"Snakemake-a scalable bioinformatics workflow engine","volume":"28","author":"K\u00f6ster","year":"2012","journal-title":"Bioinformatics"},{"issue":"7809","key":"2024121723534037300_dgae441-B22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"issue":"7","key":"2024121723534037300_dgae441-B23","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1093\/nar\/gkr1257","article-title":"A comprehensive framework for prioritizing variants in exome sequencing studies of Mendelian diseases","volume":"40","author":"Li","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2024121723534037300_dgae441-B24","first-page":"235","article-title":"dbNSFP v3.0: a one-stop database of functional predictions and annotations for human non-synonymous and splice site SNVs","volume":"37","author":"Liu","year":"2016","journal-title":"Physiol Behav"},{"issue":"1","key":"2024121723534037300_dgae441-B25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genome viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"11","key":"2024121723534037300_dgae441-B26","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"issue":"10","key":"2024121723534037300_dgae441-B27","doi-asserted-by":"crossref","first-page":"E1995","DOI":"10.1210\/jc.2012-2303","article-title":"Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas","volume":"97","author":"Newey","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2024121723534037300_dgae441-B28","doi-asserted-by":"crossref","first-page":"631680","DOI":"10.3389\/fendo.2021.631680","article-title":"Integrated whole-exome and transcriptome sequencing of sporadic parathyroid adenoma","volume":"12","author":"Hu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2024121723534037300_dgae441-B29","doi-asserted-by":"crossref","first-page":"E360","DOI":"10.1210\/jc.2014-3238","article-title":"Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion","volume":"100","author":"Yu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024121723534037300_dgae441-B30","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1002\/ijc.33166","article-title":"The genomic profile of parathyroid carcinoma based on whole-genome sequencing","volume":"147","author":"Hu","year":"2020","journal-title":"Int J Cancer"},{"issue":"6","key":"2024121723534037300_dgae441-B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.92061","article-title":"Genomic profiling reveals mutational landscape in parathyroid carcinomas","volume":"2","author":"Pandya","year":"2017","journal-title":"Jci Insight"},{"issue":"9","key":"2024121723534037300_dgae441-B32","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ng.2702","article-title":"An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers","volume":"45","author":"Roberts","year":"2013","journal-title":"Nat Genet"},{"issue":"D1","key":"2024121723534037300_dgae441-B33","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2024121723534037300_dgae441-B34","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"Suppl 4","key":"2024121723534037300_dgae441-B35","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"issue":"8","key":"2024121723534037300_dgae441-B36","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"issue":"11","key":"2024121723534037300_dgae441-B37","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2024121723534037300_dgae441-B38","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1210\/en.2018-00246","article-title":"Whole-exome sequencing identifies novel recurrent somatic mutations in sporadic parathyroid adenomas","volume":"159","author":"Wei","year":"2018","journal-title":"Endocrinology"},{"issue":"7","key":"2024121723534037300_dgae441-B39","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/clinem\/dgad002","article-title":"Genomic profiling reveals the variant landscape of sporadic parathyroid adenomas in Chinese population","volume":"108","author":"Tao","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024121723534037300_dgae441-B40","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s12276-023-00968-4","article-title":"Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma","volume":"55","author":"Jo","year":"2023","journal-title":"Exp Mol Med"},{"issue":"3","key":"2024121723534037300_dgae441-B41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/js.2018-00043","article-title":"Comprehensive genomic characterization of parathyroid cancer identifies novel candidate driver mutations and core pathways","volume":"3","author":"Clarke","year":"2019","journal-title":"J Endocr Soc"},{"issue":"2","key":"2024121723534037300_dgae441-B42","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-18-0304","article-title":"Molecular genetic insights into sporadic primary hyperparathyroidism","volume":"26","author":"Brewer","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"19","key":"2024121723534037300_dgae441-B43","first-page":"5553","article-title":"Screening of the MEN1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors","volume":"60","author":"Uchino","year":"2000","journal-title":"Cancer Res"},{"issue":"11","key":"2024121723534037300_dgae441-B44","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/BF03345303","article-title":"Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics","volume":"27","author":"Scarpelli","year":"2004","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"2024121723534037300_dgae441-B45","first-page":"2960","article-title":"Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism","volume":"83","author":"Carling","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024121723534037300_dgae441-B46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ng0897-375","article-title":"Somatic mutation of the MEN1 gene in parathyroid tumours","volume":"16","author":"Heppner","year":"1997","journal-title":"Nat Genet"},{"issue":"8","key":"2024121723534037300_dgae441-B47","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1054\/bjoc.2000.1380","article-title":"Identification of MEN1 gene mutations in families with MEN 1 and related disorders","volume":"83","author":"Bergman","year":"2000","journal-title":"Br J Cancer"},{"issue":"6","key":"2024121723534037300_dgae441-B48","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/BF03345492","article-title":"MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism","volume":"25","author":"Cetani","year":"2002","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2024121723534037300_dgae441-B49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1660001","article-title":"Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region","volume":"166","author":"Karges","year":"2000","journal-title":"J Endocrinol"},{"issue":"1","key":"2024121723534037300_dgae441-B50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/eje.0.1430047","article-title":"Frequency of somatic MEN 1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism","volume":"143","author":"Miedlich","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2024121723534037300_dgae441-B51","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12020-016-0941-6","article-title":"Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas","volume":"55","author":"Borsari","year":"2016","journal-title":"Endocrine"},{"issue":"2","key":"2024121723534037300_dgae441-B52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/EJE-12-0327","article-title":"MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism","volume":"168","author":"Alvelos","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2024121723534037300_dgae441-B53","doi-asserted-by":"crossref","first-page":"360","DOI":"10.18632\/oncoscience.38","article-title":"Recurrent ZFX mutations in human sporadic parathyroid adenomas","volume":"1","author":"Soong","year":"2014","journal-title":"Oncoscience"},{"issue":"3","key":"2024121723534037300_dgae441-B54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1067\/msy.2000.104165","article-title":"Somatic mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in patients with sporadic, nonfamilial primary hyperparathyroidism","volume":"127","author":"Sato","year":"2000","journal-title":"Surgery"},{"issue":"8","key":"2024121723534037300_dgae441-B55","first-page":"2627","article-title":"Alterations of the MEN1 gene in sporadic parathyroid tumors","volume":"83","author":"Farnebo","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024121723534037300_dgae441-B56","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2265.2007.02894.x","article-title":"Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas","volume":"67","author":"Haven","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024121723534037300_dgae441-B57","doi-asserted-by":"crossref","first-page":"2080797","DOI":"10.1155\/2020\/2080797","article-title":"Rare somatic MEN1 gene pathogenic variant in a patient affected by atypical parathyroid adenoma","volume":"2020","author":"Cinque","year":"2020","journal-title":"Int J Endocrinol"},{"issue":"3","key":"2024121723534037300_dgae441-B58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/(SICI)1097-0215(19990129)80:3<373::AID-IJC7>3.0.CO;2-B","article-title":"MEN1 gene mutation analysis of sporadic adrenocortical lesions","volume":"80","author":"G\u00f6rtz","year":"1999","journal-title":"Int J Cancer"},{"issue":"12","key":"2024121723534037300_dgae441-B59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5483\/BMBRep.2022.55.12.174","article-title":"The role of EZH1 and EZH2 in development and cancer","volume":"55","author":"Lee","year":"2022","journal-title":"BMB Rep"},{"issue":"2","key":"2024121723534037300_dgae441-B60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/ERC-13-0497","article-title":"The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors","volume":"21","author":"Svedlund","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2024121723534037300_dgae441-B61","doi-asserted-by":"crossref","first-page":"11384","DOI":"10.1038\/ncomms11384","article-title":"Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance","volume":"7","author":"Brooun","year":"2016","journal-title":"Nat Commun"},{"issue":"8","key":"2024121723534037300_dgae441-B62","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00432-019-02945-9","article-title":"Genetic profiling as a clinical tool in advanced parathyroid carcinoma","volume":"145","author":"Kutahyalioglu","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"2024121723534037300_dgae441-B63","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.31948","article-title":"Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas","volume":"144","author":"Cui","year":"2019","journal-title":"Int J Cancer"},{"issue":"6","key":"2024121723534037300_dgae441-B64","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1634\/theoncologist.2018-0334","article-title":"Genomic profiling of parathyroid carcinoma reveals genomic alterations suggesting benefit from therapy","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"key":"2024121723534037300_dgae441-B65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.4203","article-title":"Complete genomic landscape of a recurring sporadic parathyroid carcinoma","volume":"230","author":"Kasaian","year":"2013","journal-title":"J Pathol"},{"issue":"18","key":"2024121723534037300_dgae441-B66","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1080\/15384101.2020.1806448","article-title":"The PRC2 complex directly regulates the cell cycle and controls proliferation in skeletal muscle","volume":"19","author":"Adhikari","year":"2020","journal-title":"Cell Cycle"},{"issue":"3","key":"2024121723534037300_dgae441-B67","first-page":"239","article-title":"EZH2 activates Wnt\/(-catenin signaling in human uterine fibroids, which is inhibited by the natural compound methyl jasmonate","volume":"4","author":"Ali","year":"2023","journal-title":"F S Sci"},{"issue":"2","key":"2024121723534037300_dgae441-B68","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbrc.2006.11.056","article-title":"Activated (-catenin in the novel human parathyroid tumor cell line sHPT-1","volume":"352","author":"Bj\u00f6rklund","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2024121723534037300_dgae441-B69","first-page":"726","article-title":"Menin represses tumorigenesis via repressing cell proliferation","volume":"1","author":"Wu","year":"2011","journal-title":"Am J Cancer Res"},{"issue":"5","key":"2024121723534037300_dgae441-B70","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.surg.2007.12.012","article-title":"Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations","volume":"143","author":"Sarquis","year":"2008","journal-title":"Surgery"},{"issue":"3","key":"2024121723534037300_dgae441-B71","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2006.02460.x","article-title":"Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours","volume":"64","author":"Bradley","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2024121723534037300_dgae441-B72","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","article-title":"HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours","volume":"40","author":"Howell","year":"2003","journal-title":"J Med Genet"},{"issue":"11","key":"2024121723534037300_dgae441-B73","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","article-title":"Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors","volume":"89","author":"Cetani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024121723534037300_dgae441-B74","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1210\/jc.2005-0717","article-title":"HRPT2 mutational analysis of typical sporadic parathyroid adenomas","volume":"90","author":"Krebs","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024121723534037300_dgae441-B75","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ando.2023.06.003","article-title":"Parathyroid cancer with MTOR gene mutation: case report and review of the literature","volume":"84","author":"Stark","year":"2023","journal-title":"Ann Endocrinol (Paris)"},{"issue":"12","key":"2024121723534037300_dgae441-B76","first-page":"1","article-title":"Class I phosphoinositide 3-kinase PIK3CA\/p110( and PIK3CB\/p110( isoforms in endometrial cancer","volume":"19","author":"Gavgani","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2024121723534037300_dgae441-B77","doi-asserted-by":"crossref","first-page":"e1003895","DOI":"10.1371\/journal.pcbi.1003895","article-title":"Investigating the structure and dynamics of the PIK3CA wild-type and H1047R oncogenic mutant","volume":"10","author":"Gkeka","year":"2014","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"2024121723534037300_dgae441-B78","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/jbm4.10360","article-title":"PIK3CA mutational analysis of parathyroid adenomas","volume":"4","author":"Riccardi","year":"2020","journal-title":"JBMR Plus"},{"issue":"2","key":"2024121723534037300_dgae441-B79","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","article-title":"The parafibromin tumor suppressor protein is part of a human Paf1 complex","volume":"25","author":"Rozenblatt-Rosen","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"15","key":"2024121723534037300_dgae441-B80","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1016\/j.molcel.2021.05.028","article-title":"Two distinct mechanisms of RNA polymerase II elongation stimulation in vivo","volume":"81","author":"\u017dumer","year":"2021","journal-title":"Mol Cell"},{"issue":"7_Suppl","key":"2024121723534037300_dgae441-B81","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1158\/1538-7445.AM2023-5279","article-title":"Molecular analysis of AMBRA1 as a candidate tumor suppressor in sporadic parathyroid adenomas","volume":"83","author":"Chinwo","year":"2023","journal-title":"Cancer Res"},{"issue":"7793","key":"2024121723534037300_dgae441-B82","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"Campbell","year":"2020","journal-title":"Nature"},{"issue":"7","key":"2024121723534037300_dgae441-B83","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2217\/epi-2018-0195","article-title":"BCOR involvement in cancer","volume":"11","author":"Astolfi","year":"2019","journal-title":"Epigenomics"},{"issue":"2","key":"2024121723534037300_dgae441-B84","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1158\/2643-3230.BCD-21-0115","article-title":"BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PRC1.1 from target genes","volume":"3","author":"Schaefer","year":"2022","journal-title":"Blood Cancer Discov"},{"issue":"6","key":"2024121723534037300_dgae441-B85","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.devcel.2015.04.006","article-title":"Kdm2a\/b lysine demethylases regulate canonical Wnt signaling by modulating the stability of nuclear \u03b2-catenin","volume":"33","author":"Lu","year":"2015","journal-title":"Dev Cell"},{"issue":"1","key":"2024121723534037300_dgae441-B86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molcel.2011.05.014","article-title":"SHP2 tyrosine phosphatase converts parafibromin\/Cdc73 from a tumor suppressor to an oncogenic driver","volume":"43","author":"Takahashi","year":"2011","journal-title":"Mol Cell"},{"issue":"1","key":"2024121723534037300_dgae441-B87","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1038\/ncomms6809","article-title":"Targeting beta-catenin signaling for therapeutic intervention in MEN1-deficient pancreatic neuroendocrine tumours","volume":"5","author":"Jiang","year":"2014","journal-title":"Nat Commun"},{"issue":"1","key":"2024121723534037300_dgae441-B88","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.devcel.2015.12.015","article-title":"Endothelial RSPO3 controls vascular stability and pruning through non-canonical WNT\/Ca2+\/NFAT signaling","volume":"36","author":"Scholz","year":"2016","journal-title":"Dev Cell"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae441\/58528452\/dgae441.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/1\/48\/61213702\/dgae441.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/1\/48\/61213702\/dgae441.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T23:54:54Z","timestamp":1734479694000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/1\/48\/7700987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,6,28]]},"published-print":{"date-parts":[[2024,12,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae441","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,6,28]]}}}